Study Results from Icahn School of Medicine at Mount Sinai in the Area of Liver Cancer Reported (Wntinib Is a Multi-kinase Inhibitor With Specificity Against & Beta;-catenin Mutant Hepatocellular Carcinoma)

Press/Media

Period	6 Sep 2023

Media coverage

Title	Study Results from Icahn School of Medicine at Mount Sinai in the Area of Liver Cancer Reported (Wntinib Is a Multi-kinase Inhibitor With Specificity Against & Beta;-catenin Mutant Hepatocellular Carcinoma)
Media name/outlet	Genomics & Genetics Daily
Country/Territory	United States
Date	6/09/23
URL	ct.moreover.com/?a=51736049233&p=1gw&v=1&x=vPTxNy6JX8ziSB43jzGfrg
Persons	Megan Schwarz, Denis Torre, Amaia Lujambio, Josep Llovet, Jian Jin, Ernesto Guccione, Augusto Villanueva Rodriguez, Arvin Dar, Amaia Lujambio Goizueta, Zaigham Khan